Expression and function of C5a receptor in mouse microvascular endothelial cells

Area of Science:

• Immunology
• Cell Biology
• Endothelial Cell Biology

Background:

• The complement system's anaphylatoxin C5a (complement component 5a) is a potent inflammatory mediator.
• C5a exerts its effects through binding to the C5a receptor (C5aR; CD88).
• Understanding C5aR regulation on endothelial cells is crucial for inflammatory disease research.

Purpose of the Study:

• To investigate the specific binding of C5a to mouse dermal microvascular endothelial cells (MDMEC).
• To determine the effect of inflammatory stimuli on C5aR expression and function in MDMEC.
• To explore the role of C5a in modulating endothelial cell inflammatory mediator production.

Main Methods:

• Radioligand binding assays using radiolabeled recombinant mouse C5a (rmC5a).
• Confocal microscopy to detect C5aR expression on MDMEC.
• In vitro stimulation of MDMEC with C5a, IL-6, LPS, and IFN-gamma.
• Measurement of C5aR mRNA and inflammatory mediator (MIP-2, MCP-1) production.
• In vivo immunostaining of mouse lung endothelium after LPS infusion.

Main Results:

• Specific binding of rmC5a to MDMEC was demonstrated, with approximately 15,000-20,000 C5aR per cell.
• In vitro exposure to LPS, IFN-gamma, or IL-6 increased C5aR mRNA and surface expression on MDMEC.
• C5a alone did not induce MIP-2 or MCP-1 production, but synergistic effects were observed when MDMEC were pre-exposed to IL-6, LPS, or IFN-gamma.
• In vivo, LPS infusion led to C5aR upregulation in mouse lung capillary endothelium.

Conclusions:

• C5aR is expressed on MDMEC and its expression can be upregulated by inflammatory stimuli.
• C5a, in conjunction with other inflammatory signals, can potentiate endothelial cell production of pro-inflammatory mediators.
• These findings suggest a mechanism by which C5a contributes to inflammation in microvasculature.